Aldoxorubicin
Aldoxorubicin (INNO-206) is a tumor-targeted doxorubicin conjugate in development by CytRx. Specifically, it is the (6-maleimidocaproyl) hydrazone of doxorubicin. Essentially, this chemical name describes doxorubicin attached to an acid sensitive linker (N-ε-maleimidocaproic acid hydrazide, or EMCH). The proposed mechanism of action is as follows:
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Aldoxorubicin
Aldoxorubicin (INNO-206) is a tumor-targeted doxorubicin conjugate in development by CytRx. Specifically, it is the (6-maleimidocaproyl) hydrazone of doxorubicin. Essentially, this chemical name describes doxorubicin attached to an acid sensitive linker (N-ε-maleimidocaproic acid hydrazide, or EMCH). The proposed mechanism of action is as follows:
has abstract
Aldoxorubicin (INNO-206) is a ...... ased at the site of the tumor.
@en
CAS number
1361644-26-9
FDA UNII code
C28MV4IM0B
KEGG
PubChem
Wikipage page ID
45,717,219
page length (characters) of wiki page
Wikipage revision ID
964,311,128
Link from a Wikipage to another Wikipage
CAS number
ChemSpiderID
IUPAC name
N-1-[(2S,4S)-4-[(2R,4S,5S,6S)- ...... ,5-dioxopyrrol-1-yl)hexanamide
@en
KEGG
D10383
@en
PubChem
71,300,693
SMILES
C[C@H]1[C@H]O
@en
StdInChIKey
OBMJQRLIQQTJLR-FRTGXRTISA-N
@en
UNII
C28MV4IM0B
@en
wikiPageUsesTemplate
hypernym
comment
Aldoxorubicin (INNO-206) is a ...... anism of action is as follows:
@en
label
Aldoxorubicin
@en